TruthArchive.ai - Related Video Feed

The talk discusses a 58-page document from Australia's therapeutic goods administration, revealing widespread distribution of lipid nanoparticles from the Pfizer vaccine. The nanoparticles were found in various organs, including the liver, ovaries, and bone marrow. Despite concerns about potential inflammatory reactions, the expression of spike protein was not studied. The document questions why the vaccine was approved without this crucial information. The data was available before vaccine authorization, raising doubts about the decision-making process.

The video discusses the different processes used to create COVID-19 vaccines, specifically the mRNA vaccines from Moderna and Pfizer. The first process, called Process 1, involved a synthetic PCR method and was tested on 40,000 people. However, a second process, tested on only 252 people, was used to produce vaccines for billions of people. This second process involved using a complementary DNA sequence to make the mRNA. It is revealed that this process was not properly tested and resulted in bacterial plasmid DNA contamination in the vaccines. The presence of this contamination raises concerns about potential long-term effects, such as autoimmune diseases and cancers. The video criticizes the fact that contaminated products are still being distributed despite the risks involved.

The Pfizer and Moderna vaccines contain fragments of DNA, which can integrate into the genomic DNA of cells and become a permanent part of the cell. This poses a potential risk of autoimmune attacks and future cancer. The DNA contamination occurred during the production process, where a plasmid vector was used to scale up the production of the RNA template. The regulatory threshold for DNA in vaccines is outdated and not suitable for this new type of vaccine. The speaker believes that DNA sequencing should be done on vaccinated individuals' stem cells to determine if this theoretical risk has occurred. Informed consent is necessary, and the lack of transparency regarding the DNA contamination is concerning.

The presence of DNA plasmids and undisclosed proteins in the Pfizer COVID-19 vaccine has raised concerns. The DNA plasmids, originating from E. Coli, were not properly removed during manufacturing, resulting in contamination. Additionally, two proteins from the simian virus 40 (SV40) were found in the vaccine, which is associated with certain cancers. SV40 was present in polio vaccines administered to millions of Americans in the past. Injecting these proteins and DNA into the body can potentially lead to mutations and increased risk of cancer. This discovery suggests a higher chance of mutation from the Pfizer COVID-19 vaccine.

The speaker discusses the harmful effects of the spike protein found in COVID-19 vaccines. They mention a study showing that almost a third of patients experienced neurological issues from the spike protein. They express concern about the lack of an off switch for this gene and the potential for autoimmune and neurological harm. The speaker also addresses criticism of fearmongering and highlights the connection between the spike protein and HIV. They mention studies linking COVID-19 vaccines to autism in rats and discuss the use of edible vaccines in plants. The speaker emphasizes the importance of sharing information and concludes by promoting their video game.

When COVID-19 vaccines were sequenced, commercial annotation software highlighted functional parts of the plasmids, including antibiotic resistance genes and SV40 components. The speaker claims that Pfizer had to manually remove these annotations before submitting the plasmid map to regulators. According to the speaker, regulators received the DNA sequence, but the sponsor is obligated to annotate every open reading frame and promoter, even if their function is unknown. The speaker alleges that Pfizer intentionally removed annotations, hiding them from the FDA, which the speaker believes is a violation of guidelines. The speaker suggests the reason for hiding SV40 components is due to SV40 virus contamination in polio vaccines and its debated link to cancer. The speaker asserts that while epidemiological data is confounded by vaccine shedding, laboratory studies show SV40 is a potent oncogenic virus. The speaker claims that the vaccines contain some of the more carcinogenic components of that virus, and that these sequences are functional and have consequences.

An article in Spectator Australia reported that DNA plasmids are contaminated with SV40 promoter sequences, which are oncogenic and used in cancer development in mice. The speaker questions why this is in an RNA vaccine, as the presence of DNA means it can integrate. Despite claims that the spike protein stays at the injection site, it has been identified everywhere, including in metastases from a colorectal cancer case where spike messenger RNA from the vaccine insertion was confirmed. The speaker was refused autopsies, even with consent from relatives, including a case of explosive melanoma after a booster shot. A report in The Lancet about deaths after vaccines was pulled, allegedly due to improper peer review. The speaker claims a media channel warned them that the government had made it a crime to criticize the vaccine program on the media.

A biochemist and toxicologist discusses concerns about the Pfizer vaccine. They claim that the vaccine contains plasma DNA, including SV40 sequences, which were not disclosed to regulators. They believe this is intentional and could lead to DNA integration and potential cancer risks. The speaker argues that the DNA in the vaccine is different from RNA and can be permanent. They suggest that safer alternatives like hydroxychloroquine and ivermectin exist and question the transparency of the FDA. They urge states to protect their citizens and reconsider the use of the vaccine, especially for pregnant women and children.

In this video, the speaker discusses concerns about the Pfizer vaccine and the regulatory process. They mention that the plasmid used in the vaccine was intentionally modified, and regulators are aware of this but have not taken action. The speaker also highlights a Moderna patent that suggests quantitative PCR undercounts DNA in the vaccines. They discuss the potential risks of DNA contamination and its impact on tumor suppressor genes. The speaker raises concerns about the FDA's revolving door culture and the need to screen the blood supply and fertility clinics. They mention studies showing the presence of nucleic acids in breast milk and raise questions about transplant organ issues and cancer biopsies. The speaker offers PCR primers for testing and encourages others to try it themselves.

Kevin McKernan, an experienced genomic expert, discusses his findings regarding mRNA vaccines. He discovered that the expression vectors for the vaccines, which are used to produce the spike protein, are still present in the vials. These vectors exceed the guidelines set by the EMA and FDA. McKernan explains the two different processes used in the clinical trials and how residual plasmids from E. coli amplification remain in the vaccines. He specifically highlights the presence of the SV40 promoter in Pfizer vaccines, which was not disclosed to the regulatory agencies. McKernan's team conducted quantitative PCR assays and found high levels of vector DNA in the vials. He emphasizes the importance of understanding the potential risks associated with this contamination and encourages others to replicate his work.

The speaker discusses issues with RNA vaccines, such as frame shifting and template switching, potentially leading to the production of abnormal proteins. They highlight concerns about mitochondrial sequences in vaccines causing adverse effects in patients. The conversation delves into the risks of amyloidogenic proteins and their ability to trigger a chain reaction of misfolding, leading to serious health implications. The speaker emphasizes the need for further research and vigilance in monitoring potential risks associated with RNA vaccines.

The speaker discusses the inflammatory and amyloidogenic effects of small sequences called epitopes, which can cause memory dysfunction in mice. They also mention a study that found the introduction of gene transfection technologies containing the spike protein can induce amyloidogenic cascades. The speaker highlights a 200% increase in the diagnosis of CJD in France after the rollout of vaccination programs, suggesting a potential link. They discuss the loss of cognitive function associated with exposure to the spike protein and propose that amyloidogenic disease processes may underlie long-haul COVID-19 symptoms. The speaker mentions the role of viral infections in facilitating intercellular aggregate dissemination and shares examples of misfolding prion amyloidogenic diseases.

In this video, the speakers discuss the omission of the SV40 promoter sequence in the plasmid used in vaccines. They highlight that the plasmid was annotated with various details except for the SV40 region, which is active in a million cells. Health Canada stated that sponsors should identify any biologically functional DNA, such as the SV40 enhancer, during submission. However, Pfizer did not specifically identify the SV40 sequence. The speakers explain that the plasmid map provided by Pfizer did not include annotations for the SV40 region or the F1 origin. They speculate that this omission was intentional and not a simple oversight. The speakers also mention the use of SnapGene software for plasmid annotation.

In this video, the speakers discuss new information about the mRNA vaccines and the presence of DNA in them. Researchers have found that some mRNA vaccines contain DNA fragments, which can cause issues with gene expression and potentially increase the risk of cancer. The presence of DNA in the vaccines is a manufacturing problem, and it is unclear why it was included. The DNA can enter cells and interfere with important genes, leading to various health problems. The speakers emphasize the need to investigate the extent of DNA contamination in the vaccines and consider stopping their production until the issue is resolved.

Key points: "the vials that were in fact approved are not the vials that were given to the public." The clinical trial used "process one that used PCR to make the DNA that was going to then turn into the RNA to make the spike protein." After the trial, "they switched" to a production process that "manufactured this DNA in E. Coli," introducing endotoxin risk. "There are these plasmids that have additional DNA that were not present in the actual clinical trial." Sequencing found mixtures, including "expired" and samples that had "been tapped into." Regarding Pfizer, "the Pfizer vaccines actually had a component that was not disclosed to the regulators." "The plasmid map on the right is what was disclosed to the EMA" with "no mention of the SV40 components" now "inside this DNA sequence." "The plasma on the left is what we actually found," with components not disclosed to regulators nor to patients. Monovalent Pfizer; prior ones were the bivalent vaccines from Moderna and Pfizer.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification and autoimmune attacks. There is a theoretical risk of future cancer as well. The speaker emphasizes the need to investigate these concerns further.

Pfizer's use of the RiboGreen technique to measure DNA in their vaccines has raised concerns about deceptive practices. The presence of billions of DNA fragments in each dose, some of which are small and more likely to integrate into the genome, is worrying. Preliminary data suggests a correlation between adverse events and contaminated Pfizer vaccines, but more research is needed. The DNA in the vaccines is different from previous contamination and carries a higher risk of integration. The FDA acknowledges the integration risk and the need for lower limits on DNA when copy numbers are high. The DNA is encapsulated in lipid nanoparticles, making it prothrombotic and potentially oncogenic. The presence of endotoxin and the spike protein in the vaccines further complicates the situation. The vaccines have been found in various tissues and can lead to prolonged expression of the spike protein. Insertional mutagenesis and cancer risk are concerns, especially for individuals with weakened immune systems. Regulatory bodies have confirmed the presence of the SV40 sequence in the vaccines, but the clinical implications are still unclear.

"Pfizer vaccine is contaminated with plasma DNA. It's not just mRNA." "This DNA is the DNA vector that was used as the template for the in vitro transcription reaction when they made the mRNA." "I sequenced it in my own lab." "The vials of Pfizer vaccine that were given out here in Colombia, one of my colleagues was in charge of that vaccination program in the College of Pharmacy." "And for reasons that I still don't understand, he kept every single vial." "So he had a whole freezer full of the empty vials." "And I checked these two batches, and I checked them by sequencing." "It's surprising that there's any DNA in there." "This DNA, in my view, it could be causing some of the rare but serious side effects like death from cardiac arrest."

The speaker, a viral immunologist, discusses the presence of bacterial plasma DNA in the Pfizer and Moderna COVID-19 vaccines. They explain that the DNA is not supposed to be there and that its presence indicates improper manufacturing. The speaker highlights the potential dangers of bacterial DNA, including its ability to activate the immune system and promote inflammation. They also suggest that the DNA could lead to prolonged expression of the spike protein and raise concerns about legal immunity for the manufacturers. The speaker calls for a worldwide moratorium on the technology until further research is conducted.

The video discusses the potential adverse effects of the spike protein in SARS-CoV-2 on human prion protein and amyloid fibril formation. The speaker highlights a study showing that spike amyloid fibrils can accelerate the formation of amyloid fibrils associated with prion diseases and Alzheimer's. They also mention recent research suggesting that other viruses, like H5N1 influenza, may impact and misfold prion protein. The speaker emphasizes the importance of understanding these interactions and their potential implications. They briefly mention the symptoms and diagnostic challenges of prion diseases like Creutzfeldt-Jakob disease. Overall, the video explores the role of the spike protein in amyloidosis and its potential impact on neurological tissues.

The panel discusses replication (replicon) vaccines and their potential dangers, focusing on how they differ from conventional messenger RNA (mRNA) vaccines and what new risks might emerge as this technology develops. Key points and concerns raised - Replicon vaccines concept and fundamental differences - Replicon vaccines use replication-capable genetic material, so the embedded genetic information not only makes antigen proteins but also multiplies inside the cell. They are described as having both constitutive function (the ability to make proteins) and, crucially, the capacity to replicate, which distinguishes them from traditional, non-replicating mRNA vaccines. - It is explained that replication introduces additional mutation and recombination opportunities, because the RNA genome is copied more than once, and the process can produce variants that differ from the original design. - Central dogma exceptions and viral biology - The speakers explain that while the central dogma (DNA → RNA → protein) generally governs biology, some viruses violate this, with RNA viruses that replicate via RNA-dependent replication and even some reverse-transcribing retroviruses that convert RNA to DNA and integrate into genomes. This context is used to frame why replicon vaccines could behave unpredictably. - Potential risks of replication and spread - A core concern is that the replicon approach might allow the vaccine genome to spread beyond the initial target cells, potentially reaching other cells and tissues, or even spreading to other people via exosomes or other means. Exosomes can transport DNA, RNA, and proteins between cells; thus, the replicon genome could in theory be disseminated. - The possibility of homologous or heterologous recombination between replicon genomes and wild-type viruses could yield new variants. The panel emphasizes the difficulty of controlling such recombination in a living system. - Specific material and design considerations - The use of viral components like spike protein genes in replicon vaccines raises concerns about how these proteins might mutate or recombine during replication, potentially altering antigen presentation or safety. - A concern is raised about the lack of repair mechanisms in RNA replication (as opposed to DNA replication), which could make error rates higher and lead to unpredictable changes. - The panel notes that current replicon vaccine designs (including those using alphavirus backbones) inherently carry high mutation and recombination risk, and that the replicating systems may encounter unpredictable evolutionary dynamics inside the human body. - Safety signals and clinical anecdotes - The speakers cite cases of adverse events temporally associated with vaccines, including vascular inflammation and thrombosis, stroke-like events, and myocarditis, to illustrate that immune responses to vaccines can be complex and occasionally severe. They emphasize that such observations do not establish causality, but argue they warrant careful scrutiny. - There are references to cases of acute vascular and neural complications following repeated vaccination, and to broader immune dysregulation phenomena, including IGG4-related disease and immune dysregulation syndromes that can involve multiple organs. - One example concerns a patient who developed sudden limb problems after the third dose, requiring surgery; another describes myocardial involvement after multiple doses and subsequent inflammatory sequelae. - DNA contamination and analytical findings - Kevin McKernan’s analysis of certain Japanese CoronaVac vaccines is cited: both DNA contamination and the presence of SV40 promoter elements were detected in some vaccine lots, with DNA amounts exceeding some regulatory benchmarks in at least one case. The concern is that DNA contamination, or the presence of promoter sequences, could influence integration or expression in unintended ways. - It is noted that vaccines using lipid nanoparticles can potentially deliver nucleic acids into cells; in the presence of exons or promoter sequences, there could be unintended cellular uptake and expression. - Implications for public health and policy - The panel underscores the need for caution, thorough investigation, and long-term observation of any replication-based vaccine platform before broad deployment. There is a call to evaluate risks, monitor long-term outcomes, and consider the possibility that replication-competent constructs could drive unforeseen evolutionary dynamics within hosts or communities. - There is contention about how information is communicated to the public, with particular emphasis on avoiding misinformation while ensuring that scientific uncertainties are transparently discussed. - Broader scientific context and forward-looking stance - The speakers discuss how the field’s approach to gene-based vaccines is evolving rapidly, and they stress that the compatibility of replicon systems with human biology is not yet fully understood. - They frame their discussion as not merely about current vaccines but about the trajectory of vaccine platforms: if replication-based or self-dispersing systems prove too risky or unpredictable, the prudent path might be to favor conventional, non-replicating strategies until safety, efficacy, and containment of unintended spread are more firmly established. Closing and takeaways - The session closes with emphasis on careful evaluation of replicon vaccines, awareness that viral genetics can behave differently in humans than in theory, and a call for continued discussion, independent verification, and transparent communication as the technology develops. - Throughout, speakers acknowledge the complexity of immune responses to vaccines, the potential for unexpected adverse events, and the importance of safeguarding public health while advancing vaccine science.

The Pfizer vaccine is contaminated with plasma DNA, not just mRNA. This DNA is the DNA vector used as the template for the in vitro transcription reaction. This was discovered by sequencing vials of Pfizer vaccine from Colombia. It's surprising that there's any DNA in there. The speaker is alarmed about the possible consequences of this, including rare but serious side effects like death from cardiac arrest. Mixing DNA with a lipid complex allows it to enter cells and become a permanent fixture. This is a real hazard for genome modification of long-lived somatic cells, like stem cells, and could cause a sustained autoimmune attack. There is also a very real theoretical risk of future cancer in some people. The risk is not zero and it may be high enough that we ought to figure out if this is happening or not.

The speaker discusses the presence of DNA in the Pfizer vaccine and expresses concern about its potential consequences. They explain that they sequenced the DNA in the vaccine and found it surprising that any DNA was present. The speaker suggests that this DNA could be causing rare but serious side effects, such as death from cardiac arrest. They also mention that the DNA could integrate into the genomic DNA of cells, potentially leading to genome modification, autoimmune attacks, or even future cancer. The speaker acknowledges that these concerns are theoretical but believes they warrant further investigation.

In this video, the speaker discusses some findings from their investigations into COVID-19 vaccines. They mention a sample that showed no phosphorus, which could be experimental error. They also found small specks of copper in some vaccines, but the reason for this is unknown. The speaker then talks about their own experiment where they added the Pfizer vaccine to blood and observed discoloration and clumping of red blood cells. They suggest that this could be due to the cationic lipid in the vaccine coming into contact with cell membranes. They emphasize the importance of informed consent and the need for more research on these vaccine effects.

The video discusses the presence of SV40 (simian virus 40) in COVID genetic vaccines and its potential link to cancer. The speaker clarifies that while the vaccines do not contain the entire virus, they do contain the promoter and enhancer from SV40, which could increase the risk of DNA integration and potential oncogenesis. The speaker also mentions the role of lipid nanoparticles in vaccine delivery and the need for further research on their toxicity. Additionally, concerns are raised about the biodistribution of the vaccines and their potential impact on the germline. The speaker emphasizes the importance of understanding these risks and considering alternative approaches to respiratory virus vaccination.